RCM
AXSM icon

RA Capital Management’s Axsome Therapeutics AXSM Stock Holding History

RA Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,000,000
Closed -$84.6M – 88
2024
Q4 		$84.6M Hold
1,000,000
– – 1.13% 22
2024
Q3 		$89.9M Hold
1,000,000
– – 1.04% 28
2024
Q2 		$80.5M Hold
1,000,000
– – 1.06% 26
2024
Q1 		$79.8M Hold
1,000,000
– – 1.02% 28
2023
Q4 		$79.6M Hold
1,000,000
– – 1.24% 24
2023
Q3 		$69.9M Hold
1,000,000
– – 1.38% 22
2023
Q2 		$71.9M Buy
+1,000,000
New +$73.8M 1.36% 21
2021
Q3 		– Sell
-1,655,447
Closed -$112M – 97
2021
Q2 		$112M Hold
1,655,447
– – 1.79% 15
2021
Q1 		$93.7M Hold
1,655,447
– – 1.41% 19
2020
Q4 		$135M Sell
1,655,447
-379,685
-19% -$28.4M 1.89% 11
2020
Q3 		$145M Hold
2,035,132
– – 2.65% 7
2020
Q2 		$167M Buy
2,035,132
+131,038
+7% +$10.1M 3.26% 7
2020
Q1 		$112M Buy
1,904,094
+1,536,278
+418% +$125M 3.54% 6
2019
Q4 		$38M Sell
367,816
-296,569
-45% -$12M 1.15% 21
2019
Q3 		$13.4M Sell
664,385
-676,443
-50% -$17.4M 0.8% 24
2019
Q2 		$34.5M Sell
1,340,828
-1,952,961
-59% -$39.1M 1.85% 15
2019
Q1 		$46.9M Buy
+3,293,789
New +$30.6M 2.02% 14

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

RA Capital Management's AXSM Position: Q1 2025 in Review

RA Capital Management sold out of Axsome Therapeutics (AXSM) in Q1 2025, closing a stake of 1,000,000 shares — an estimated $84.6M sold.

RA Capital Management first reported a position in AXSM in Q1 2019 and held it in 17 quarters. The position peaked at $167M in Q2 2020. 352 funds tracked by Wall St. Rank hold AXSM as of Q1 2025.

  • RA Capital Management reported no remaining Axsome Therapeutics position as of Q1 2025 after selling out during the quarter.
  • RA Capital Management sold 1,000,000 Axsome Therapeutics shares in Q1 2025, an estimated $84.6M.
  • RA Capital Management first reported a position in Axsome Therapeutics in Q1 2019 and held it in 17 quarters.
  • RA Capital Management's Axsome Therapeutics position peaked at $167M in Q2 2020.
  • 352 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2025.

Based on RA Capital Management's 13F filing for Q1 2025, filed 15 May 2025.